CytomX Therapeutics, Inc. (CTMX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
CytomX Therapeutics Inc CTMX
$2.97
▲ +0.34%
(+$0.01)
Open
$3.03
Prev Close
$2.96
Day Range
$2.89 – $3.07
52W Range
$1.72 – $8.21
Market Cap
$642.22M
Beta
2.18
EPS (TTM)
$-0.35
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2015-10-08 |
| Shares Out. | 217,700,000 |
| Website | cytomx.com/ ↗ |
| Phone | 16505153185 |
CytomX Therapeutics Inc is a publicly traded company under the ticker symbol CTMX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
15 analysts (2026-06-01)